Bio-Rad Laboratories, Inc. Class A Common Stock (BIO)

Total Debt

$1.20B

Quarterly · Period ending: · USD

BIO logo

BIO Total Debt

Latest reported$1.20B
BIO Quarterly Total Debt ($24.90M → $1.20B)
High-resolution chart · PNG

BIO total debt history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Bio-Rad Laboratories, Inc. Class A Common Stock Total Debt — Quarterly (USD)
Period endingTotal Debt (USD)
1,203,700,000
1,378,200,000
1,531,000,000
1,395,300,000
1,406,500,000
1,369,500,000
1,374,700,000
1,388,115,000
1,392,671,000
1,399,739,000
1,405,443,000
1,405,471,000
1,382,252,000
1,381,713,000
1,388,098,000
1,378,954,000
1,391,664,000
1,404,177,000
223,376,000
235,825,000
222,801,000
231,062,000
225,735,000
645,331,000
645,744,000
648,392,000
651,183,000
665,894,000
661,124,000
666,371,000
439,430,000
440,575,000
440,497,000
435,047,000
435,001,000
434,927,000
434,891,000
434,755,000
434,520,000
434,434,000
434,351,000
434,276,000
434,181,000
436,107,000
435,928,000
435,925,000
435,975,000
437,210,000
437,332,000
437,343,000
437,401,000
437,246,000
734,493,000
734,284,000
734,164,000
732,539,000
732,837,000
732,708,000
732,512,000
732,403,000
732,694,000
741,483,000
964,281,000
742,735,000
744,089,000
743,766,000
743,051,000
744,033,000
744,328,000
450,462,000
455,557,000
458,264,000
455,367,000
458,123,000
457,432,000
431,048,000
430,769,000
430,113,000
428,667,000
429,518,000
430,351,000
429,756,000
429,028,000
434,797,000
437,343,000
435,465,000
435,436,000
234,466,000
236,085,000
234,701,000
236,258,000
234,808,000
112,345,000
110,008,000
113,254,000
149,509,000
160,573,000
184,438,000
198,354,000
211,275,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.